The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 186,421 | 519,033 | SH | SOLE | 519,033 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 54,566 | 2,337,877 | SH | SOLE | 2,337,877 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 643 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 36,411 | 55,405 | SH | SOLE | 55,405 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259202 | 1,031 | 200,919 | SH | SOLE | 200,919 | 0 | 0 | ||
ALKERMES PLC | COM | G01767105 | 17,543 | 754,200 | SH | SOLE | 754,200 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 116,817 | 10,114,043 | SH | SOLE | 10,114,043 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 15,172 | 436,592 | SH | SOLE | 436,592 | 0 | 0 | ||
ASTRAZENECA PLC-SPONS ADR | COM | 046353108 | 1,704 | 29,260 | SH | SOLE | 29,260 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 92,369 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 195,514 | 2,212,950 | SH | SOLE | 2,212,950 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 10,834 | 3,997,826 | SH | SOLE | 3,997,826 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 5,638 | 123,686 | SH | SOLE | 123,686 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 41,197 | 1,615,570 | SH | SOLE | 1,615,570 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 13,713 | 5,485,213 | SH | SOLE | 5,485,213 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 20,052 | 1,772,950 | SH | SOLE | 1,772,950 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 30,302 | 2,356,282 | SH | SOLE | 2,356,282 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 164,140 | 6,025,706 | SH | SOLE | 6,025,706 | 0 | 0 | ||
KALEIDO BIOSCIENCES INC | COM | 483347100 | 815 | 341,030 | SH | SOLE | 341,030 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 35,175 | 5,470,452 | SH | SOLE | 5,470,452 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 10,972 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 1,915 | 432,300 | SH | SOLE | 432,300 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q200 | 372 | 31,330 | SH | SOLE | 31,330 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,032 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | ||
NOVAVAX INC | COM | 670002401 | 1,788 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
PROTHENA CORP PLC | COM | G72800108 | 83,253 | 1,685,282 | SH | SOLE | 1,685,282 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 71,308 | 4,369,366 | SH | SOLE | 4,369,366 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM | 766559603 | 1,729 | 652,395 | SH | SOLE | 652,395 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 33,255 | 781,730 | SH | SOLE | 781,730 | 0 | 0 | ||
STAAR SURGICAL CO | COM | 852312305 | 104,129 | 1,140,511 | SH | SOLE | 1,140,511 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 13,110 | 598,900 | SH | SOLE | 598,900 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 516 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 5,155 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 148,491 | 687,206 | SH | SOLE | 687,206 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 233 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 44,469 | 2,834,244 | SH | SOLE | 2,834,244 | 0 | 0 | ||
ZOGENIX INC | COM | 98978L204 | 2,987 | 183,800 | SH | SOLE | 183,800 | 0 | 0 |